Please login to the form below

Not currently logged in
Email:
Password:

clinical data

This page shows the latest clinical data news and features for those working in and with pharma, biotech and healthcare.

AZ’s Imfinzi combo bombs again in non-small cell lung cancer

AZ’s Imfinzi combo bombs again in non-small cell lung cancer

In a statement, AZ’s head of cancer R&D José Baselga said only that the company is “fully committed to a deep analysis of the vast clinical and biomarker data ... The readout will also be a concern to Bristol-Myers Squibb, which is relying on TMB

Latest news

More from news
Approximately 0 fully matching, plus 765 partially matching documents found.

Latest Intelligence

  • The evolution of real-world studies The evolution of real-world studies

    hard to enrol clinical trials and led to a growing role for real-world registries. ... In the document, the EMA stated that it is fostering an ‘adaptive approach’ that uses real-world data to supplement clinical trial results.

  • Streamlining clinical trials – why better data use is key Streamlining clinical trials – why better data use is key

    Blockchain. Better data use will only help industry streamline clinical development if maintenance and exchange technologies are effective, according to Pistoia Alliance President Steve Arlington. ... Greater use and adoption of data standards will be

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    VACCITECH'S PIPELINE. VTP-100's clinical phase 2b trial is just getting underway, with analysis of the clinical and virologic data by Q1 2020.  If everything proceeds to plan, when ... We are pursuing a dual clinical development pathway that will

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    clinical and genomic data for research. ... The firms will work together to combine. AZ’s genomics, chemistry and clinical data with BenevolentAI’s target identification platform and biomedical knowledge graph – a network of contextualised

  • The trials and tribulations of rare opportunities The trials and tribulations of rare opportunities

    Data mining. In clinical trials focused on common diseases, recruiters often use diagnostic data to find people. ... said. For such products, regulators have been willing to grant approval based on limited data.

More from intelligence
Approximately 0 fully matching, plus 102 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 60 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics